These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38484133)

  • 1. The Role of Inflammation and Fibrosis in Interstitial Lung Disease Treatment Decisions.
    Behr J; Salisbury ML; Walsh SLF; Podolanczuk AJ; Hariri LP; Hunninghake GM; Kolb M; Ryerson CJ; Cottin V; Beasley MB; Corte T; Glanville AR; Adegunsoye A; Hogaboam C; Wuyts WA; Noth I; Oldham JM; Richeldi L; Raghu G; Wells AU
    Am J Respir Crit Care Med; 2024 Aug; 210(4):392-400. PubMed ID: 38484133
    [No Abstract]   [Full Text] [Related]  

  • 2. Pulmonary fibrosis: from pathogenesis to clinical decision-making.
    Koudstaal T; Funke-Chambour M; Kreuter M; Molyneaux PL; Wijsenbeek MS
    Trends Mol Med; 2023 Dec; 29(12):1076-1087. PubMed ID: 37716906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Perioperative lung injury: acute exacerbation of idiopathic pulmonary fibrosis and acute interstitial pneumonia after pulmonary resection].
    Hoshikawa Y; Kondo T
    Nihon Geka Gakkai Zasshi; 2004 Dec; 105(12):757-62. PubMed ID: 15651477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics of non-idiopathic pulmonary fibrosis, progressive fibrosing interstitial lung diseases: A single-center retrospective study.
    Komatsu M; Yamamoto H; Kitaguchi Y; Kawakami S; Matsushita M; Uehara T; Kinjo T; Wada Y; Ichiyama T; Urushihata K; Ushiki A; Yasuo M; Hanaoka M
    Medicine (Baltimore); 2021 Apr; 100(13):e25322. PubMed ID: 33787626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in the pathogenesis and clinical evaluation of pulmonary fibrosis.
    Margaritopoulos GA; Romagnoli M; Poletti V; Siafakas NM; Wells AU; Antoniou KM
    Eur Respir Rev; 2012 Mar; 21(123):48-56. PubMed ID: 22379174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-MDA5 Antibody-positive Clinically Amyopathic Dermatomyositis Complicated by Unilateral Right-sided Interstitial Lung Disease.
    Kori M; Awano N; Inomata M; Kuse N; Tone M; Yoshimura H; Jo T; Takada K; Kumasaka T; Takemura T; Izumo T
    Intern Med; 2020; 59(3):401-408. PubMed ID: 32009089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of endothelial dysfunction and coagulation disorders in the development of pulmonary fibrosis in patients with interstitial lung diseases].
    Ppova EN; Arkhipova DV; Kozlovskaia LV; Privalova EV; Bitsadze VO; Kornev BM
    Klin Med (Mosk); 2004; 82(6):38-42. PubMed ID: 15344689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-Term Pulmonary Function Trends Are Predictive of Mortality in Interstitial Lung Disease Associated With Systemic Sclerosis.
    Goh NS; Hoyles RK; Denton CP; Hansell DM; Renzoni EA; Maher TM; Nicholson AG; Wells AU
    Arthritis Rheumatol; 2017 Aug; 69(8):1670-1678. PubMed ID: 28426895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia should stay separate.
    Collard HR; King TE
    Eur Respir J; 2008 May; 31(5):1141-2; author reply 1142-3. PubMed ID: 18448513
    [No Abstract]   [Full Text] [Related]  

  • 10. [Interstitial pneumonia and pulmonary fibrosis].
    Yanai M; Sasaki H
    Ryoikibetsu Shokogun Shirizu; 1994; (3):591-4. PubMed ID: 8152063
    [No Abstract]   [Full Text] [Related]  

  • 11. Thin-section computed tomography-determined usual interstitial pneumonia pattern affects the decision-making process for resection in newly diagnosed lung cancer patients: a retrospective study.
    Hashimoto N; Ando A; Iwano S; Sakamoto K; Okachi S; Matsuzaki A; Okada Y; Wakai K; Yokoi K; Hasegawa Y
    BMC Pulm Med; 2018 Jan; 18(1):2. PubMed ID: 29304775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Systemic sclerosis].
    Schinke S; Riemekasten G
    Internist (Berl); 2019 Dec; 60(12):1251-1269. PubMed ID: 31754753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host-environment interactions in exposure-related diffuse lung diseases.
    Brass DM; Wise AL; Schwartz DA
    Semin Respir Crit Care Med; 2008 Dec; 29(6):603-9. PubMed ID: 19221958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute exacerbations of interstitial lung diseases.
    Papanikolaou IC; Drakopanagiotakis F; Polychronopoulos VS
    Curr Opin Pulm Med; 2010 Sep; 16(5):480-6. PubMed ID: 20473169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Level of Chemokine CCL18 Is Associated With Pulmonary Function Deterioration, Lung Fibrosis Progression, and Reduced Survival in Systemic Sclerosis.
    Hoffmann-Vold AM; Tennøe AH; Garen T; Midtvedt Ø; Abraityte A; Aaløkken TM; Lund MB; Brunborg C; Aukrust P; Ueland T; Molberg Ø
    Chest; 2016 Aug; 150(2):299-306. PubMed ID: 26997242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting impairment of diffusing capacity for Chinese patients with lung fibrosis.
    Leung SK; Lam FM; Yew WW; Wong PC
    Respirology; 2008 Nov; 13(6):929-30. PubMed ID: 18811893
    [No Abstract]   [Full Text] [Related]  

  • 17. Microscopic polyangiitis presenting as a "pulmonary-muscle" syndrome: is subclinical alveolar hemorrhage the mechanism of pulmonary fibrosis?
    Birnbaum J; Danoff S; Askin FB; Stone JH
    Arthritis Rheum; 2007 Jun; 56(6):2065-71. PubMed ID: 17530647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smoking-related interstitial lung diseases.
    Vassallo R; Ryu JH
    Clin Chest Med; 2012 Mar; 33(1):165-78. PubMed ID: 22365253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between quantitative radiographic assessments of interstitial lung disease and physiological and clinical features of systemic sclerosis.
    Tashkin DP; Volkmann ER; Tseng CH; Kim HJ; Goldin J; Clements P; Furst D; Khanna D; Kleerup E; Roth MD; Elashoff R
    Ann Rheum Dis; 2016 Feb; 75(2):374-81. PubMed ID: 25452309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current concepts in and modes for measurement of activity in interstitial lung disease.
    Winterbauer RH
    Curr Opin Pulm Med; 1995 Sep; 1(5):358-62. PubMed ID: 9363096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.